A delicate balance

Linda F. Thompson(Oklahoma Medical Research Foundation), Hiroki Tsukamoto(Saga University), Petya Chernogorova(University Medical Center Freiburg), Robert Zeiser(University Medical Center Freiburg)
OncoImmunology
October 29, 2012
Cited by 9Open Access
Full Text

Abstract

The utility of allogeneic stem cell transplantation for treating hematologic malignancies is enhanced by the graft vs. tumor (GvT) effect, but limited by graft vs. host disease (GvHD). Studies involving the inhibition of CD73 by genetic or pharmacologic means suggest that the levels of CD73-generated adenosine may be manipulated to control GvHD, while maintaining the GvT effect.


Related Papers

No related papers found

Powered by citation graph analysis